Research Article
Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
Table 1
Clinicopathological characteristics of patients with clear cell carcinoma of the uterine cervix (
).
| Variables | | (%) |
| Age | | | <40 years | 25 | 50 | ≥40 years | 25 | 50 | FIGO 2009 stage | | | IA | 2 | 4 | IB | 34 | 68 | IIA | 12 | 24 | IIB | 2 | 4 | Tumour size | | | <4 cm | 33 | 66 | ≥4 cm | 17 | 34 | Parametrial involvement | | | Yes | 4 | 8 | No | 46 | 92 | LVSI | | | Yes | 6 | 12 | No | 44 | 88 | Depth of stromal invasion | | | <1/2 | 29 | 58 | ≥1/2 | 21 | 42 | Lymph node metastasis | | | No | 45 | 90 | Yes | 5 | 10 | Neoadjuvant therapy | | | Yes | 10 | 20 | No | 40 | 80 | Adjuvant therapy | | | Chemotherapy | 18 | 36 | Radiotherapy | 6 | 12 | Chemoradiotherapy | 22 | 44 | None | 4 | 8 |
|
|
FIGO: International Federation of Gynaecology and Obstetrics; LVSI: lymphovascular space invasion.
|